On July 17, 2025, the FDA convened a landmark panel of leading physicians, researchers, and women’s health advocates to reexamine a subject that affects millions: Hormone Replacement Therapy (HRT) for women. The session reflected a turning point—not only in how the medical community views menopause and hormone support, but also in how healthcare must evolve toward personalized, patient-centric care. Read More >